文献速递肝病

欧洲成人α-1抗胰蛋白酶Pi∗Z变异杂合子或纯合子(Pi∗MZ vs Pi∗ZZ基因型)及非携带者的肝脏表型

Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi∗Z Variant of AAT (Pi∗MZ vs Pi∗ZZ genotype) and Noncarriers.
PubMed 文献 · Gastroenterology · 2020-05-04

研究比较419例Pi∗MZ、309例Pi∗ZZ成人及284例非携带者的肝脏表型,发现Pi∗MZ者转氨酶、肝硬度及肝内AAT包涵体均低于Pi∗ZZ但高于非携带者;Pi∗MZ者肝硬度≥7.1 kPa的校正OR为4.8(95%CI 2.0-11.8)。

要点

  • Pi∗MZ成人肝硬度≥7.1 kPa比例为10%,非携带者为4%(校正OR 4.8,95%CI 2.0-11.8)。
  • Pi∗MZ者肝活检AAT包涵体检出率63%,Pi∗ZZ者为97%,且随肝纤维化分期增加。
  • 肥胖和糖尿病是Pi∗MZ者肝硬度≥7.1 kPa的最重要相关因素。

核心结论

  • Pi∗MZ成人血清转氨酶、肝内AAT包涵体和肝硬度低于Pi∗ZZ成人,但高于非携带者;这些发现有助于确定Pi∗MZ者的风险并辅助咨询。

研究设计与样本

  • 欧洲Alpha-1肝脏队列分析,纳入419例Pi∗MZ、309例Pi∗ZZ成人及284例非携带者,均行全面评估,肝硬度采用瞬时弹性成像。
  • 对肝脏活检分析组织学和生化特征;英国生物银行444,642名参与者的血清转氨酶水平被检索。

主要发现

  • 英国生物银行数据库中,Pi∗MZ者血清转氨酶水平高于非携带者。
  • Alpha-1肝脏队列中,Pi∗MZ成人血清γ-谷氨酰转移酶和肝硬度低于Pi∗ZZ成人,但高于非携带者。
  • Pi∗MZ者10% vs 非携带者4%肝硬度≥7.1 kPa(校正OR 4.8;95%CI 2.0-11.8)。
  • 肝活检AAT包涵体:Pi∗MZ者63% vs Pi∗ZZ者97%,且随肝纤维化分期增加。

关键数值与推荐

  • Pi∗MZ者肝硬度≥7.1 kPa的校正OR为4.8(95%CI 2.0-11.8),对应10% vs 4%。
  • Pi∗MZ者肝活检AAT包涵体检出率63%,Pi∗ZZ者97%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Homozygosity for the Pi∗Z variant of the gene that encodes the alpha-1 antitrypsin peptide (AAT), called the Pi∗ZZ genotype, causes a liver and lung disease called alpha-1 antitrypsin deficiency. Heterozygosity (the Pi∗MZ genotype) is a risk factor for cirrhosis in individuals with liver disease. Up to 4% of Europeans have the Pi∗MZ genotype; we compared features of adults with and without Pi∗MZ genotype among persons without preexisting liver disease. METHODS: We analyzed data from the European Alpha-1 Liver Cohort, from 419 adults with the Pi∗MZ genotype, 309 adults with the Pi∗ZZ genotype, and 284 individuals without the variant (noncarriers). All underwent a comprehensive evaluation; liver stiffness measurements (LSMs) were made by transient elastography. Liver biopsies were analyzed to define histologic and biochemical features associated with the Pi∗Z variant. Levels of serum transaminases were retrieved from 444,642 participants, available in the United Kingdom biobank. RESULTS: In the UK biobank database, levels of serum transaminases were increased in subjects with the Pi∗MZ genotype compared with noncarriers. In the Alpha-1 Liver Cohort, adults with Pi∗MZ had lower levels of gamma-glutamyl transferase in serum and lower LSMs than adults with the Pi∗ZZ variant, but these were higher than in noncarriers. Ten percent of subjects with the Pi∗MZ genotype vs 4% of noncarriers had LSMs of 7.1 kPa or more (adjusted odds ratio, 4.8; 95% confidence interval, 2.0-11.8). Obesity and diabetes were the most important factors associated with LSMs ≥7.1 kPa in subjects with the Pi∗MZ genotype. AAT inclusions were detected in liver biopsies of 63% of subjects with the Pi∗MZ genotype, vs 97% of subjects with the Pi∗ZZ genotype, and increased with liver fibrosis stages. Subjects with the Pi∗MZ genotype did not have increased hepatic levels of AAT, whereas levels of insoluble AAT varied among individuals. CONCLUSIONS: Adults with the Pi∗MZ genotype have lower levels of serum transaminases, fewer AAT inclusions in liver, and lower liver stiffness than adults with the Pi∗ZZ genotype, but higher than adults without the Pi∗Z variant. These findings should help determine risk of subjects with the Pi∗MZ genotype and aid in counseling.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Schneider CV, Hamesch K, Gross A, et al. Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi∗Z Variant of AAT (Pi∗MZ vs Pi∗ZZ genotype) and Noncarriers. Gastroenterology. 2020. PMID: 32376409. doi:10.1053/j.gastro.2020.04.058

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。